Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 201–300 of 1,002
Jeremias, A., Davies, J. E., Maehara, A., Matsumura, M., Schneider, J., Tang, K., Talwar, S., Marques, K., Shammas, N. W., Gruberg, L., et al. (2019) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.05.054 · Cited by 211
Mancini, G. B. J., Hartigan, P. M., Shaw, L. J., Berman, D. S., Hayes, S. W., Bates, E. R., Maron, D. J., Teo, K., Sedlis, S. P., Chaitman, B. R., et al. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.10.017 · Cited by 211
“The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial showed noninferiority between a strategy of initial optimal medical therapy (OMT) þ percutaneous coronary intervention (PCI) and OMT alone for prevention of death or myocardial infarction (MI) (2).”
MethodInfluentialSelf-citationStergiopoulos, K. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.1484 · Cited by 212
Schömig, A., Mehilli, J., de Waha, A., Seyfarth, M., Pache, J., & Kastrati, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.051 · Cited by 210
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Zaman, S., Wasfy, J. H., Kapil, V., Ziaeian, B., Parsonage, W. A., Sriswasdi, S., Chico, T. J. A., Capodanno, D., Colleran, R., Sutton, N. R., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00055-8 · Cited by 203
Self-citationDoes Coronary Flow Trump Coronary Anatomy?
Gould, K. L. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.06.004 · Cited by 211
Zimmermann, F. M., Omerovic, E., Fournier, S., Kelbæk, H., Johnson, N. P., Rothenbühler, M., Xaplanteris, P., Abdel-Wahab, M., Barbato, E., Høfsten, D. E., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy812 · Cited by 209
“Of note, the recent ORBITA trial comparing PCI with a sham intervention included 29% of patients with FFR negative lesions only.(26) In”
MethodShaw, L. J., Berman, D. S., Picard, M. H., Friedrich, M. G., Kwong, R. Y., Stone, G. W., Senior, R., Min, J. K., Hachamovitch, R., Scherrer-Crosbie, M., et al. (2014) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2013.10.021 · Cited by 207
“More recent series do not use this method of censoring for revascularization because recent trials failed to show a clinical benefit from coronary revascularization when compared with OMT (11,12).”
BackgroundMethodResultInfluentialSelf-citationVan Belle, E., Rioufol, G., Pouillot, C., Cuisset, T., Bougrini, K., Teiger, E., Champagne, S., Belle, L., Barreau, D., Hanssen, M., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006646 · Cited by 204
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Hopewell, S., Chan, A.-W., Collins, G. S., Hróbjartsson, A., Moher, D., Schulz, K. F., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081124 · Cited by 205
Kang, S.-J., Lee, J.-Y., Ahn, J.-M., Mintz, G. S., Kim, W.-J., Park, D.-W., Yun, S.-C., Lee, S.-W., Kim, Y.-H., Whan Lee, C., et al. (2011) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.110.959148 · Cited by 203
A Long-Term Prognostic Value of Coronary CT Angiography in Suspected Coronary Artery Disease
Andreini, D., Pontone, G., Mushtaq, S., Bartorelli, A. L., Bertella, E., Antonioli, L., Formenti, A., Cortinovis, S., Veglia, F., Annoni, A., et al. (2012) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2012.03.009 · Cited by 204
Efficacy of Ranolazine in Patients With Chronic Angina
Wilson, S. R., Scirica, B. M., Braunwald, E., Murphy, S. A., Karwatowska-Prokopczuk, E., Buros, J. L., Chaitman, B. R., & Morrow, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.037 · Cited by 198
Self-citationChiang, C.-E., Wang, T.-D., Ueng, K.-C., Lin, T.-H., Yeh, H.-I., Chen, C.-Y., Wu, Y.-J., Tsai, W.-C., Chao, T.-H., Chen, C.-H., et al. (2015) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2014.11.005 · Cited by 199
“Interestingly, the addition of PCI to optimal medical therapy as an initial management strategy did not reduce the risk of death or myocardial infarction.(162) This study confirmed that, in the era of bare metal stent, optimal medical therapy including aggressive BP-lowering is as effective as PCI in the treatment of…”
MethodKo, B. S., Cameron, J. D., Meredith, I. T., Leung, M., Antonis, P. R., Nasis, A., Crossett, M., Hope, S. A., Lehman, S. J., Troupis, J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr268 · Cited by 199
Panza, J. A., Holly, T. A., Asch, F. M., She, L., Pellikka, P. A., Velazquez, E. J., Lee, K. L., Borges-Neto, S., Farsky, P. S., Jones, R. H., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.014 · Cited by 199
“espite the accepted significance of ischemia on stress esting, the evidence supporting its role in the treatment ecisions for patients with CAD with LV dysfunction is nadequate, emanating from studies conducted in paients with normal or slightly reduced LV systolic funcion (4), from retrospective assessment of registr…”
BackgroundSelf-citationPrasad, A., Gersh, B. J., Bertrand, M. E., Lincoff, A. M., Moses, J. W., Ohman, E. M., White, H. D., Pocock, S. J., McLaurin, B. T., Cox, D. A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.063 · Cited by 198
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.010 · Cited by 196
Ganesha Babu, G., Malcolm Walker, J., Yellon, D. M., & Hausenloy, D. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq393 · Cited by 193
“Percutaneous coronary intervention improves symptoms in patients with stable CHD, but does not improve clinical outcomes.(4) About one-third of all elective PCI procedures are associated with significant myocardial injury (termed peri-procedural myocardial injury, PMI), which has been associated with increased subsequ…”
BackgroundEnsuring the integrity of clinical practice guidelines: a tool for protecting patients
Lenzer, J., Hoffman, J. R., Furberg, C. D., & Ioannidis, J. P. A. (2013) · BMJ · doi:10.1136/bmj.f5535 · Cited by 187
Who Ordered That? The Economics of Treatment Choices in Medical Care
Chandra, A., Cutler, D., & Song, Z. (2011) · Handbook of health economics · doi:10.1016/b978-0-444-53592-4.00006-2 · Cited by 257
Riley, R. F., Don, C. W., Powell, W., Maynard, C., & Dean, L. S. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958744 · Cited by 191
Teng, N., Maghzal, G. J., Talib, J., Rashid, I., Lau, A. K., & Stocker, R. (2017) · Redox Report · doi:10.1080/13510002.2016.1256119 · Cited by 189
Iqbal, J., Zhang, Y.-J., Holmes, D. R., Morice, M.-C., Mack, M. J., Kappetein, A. P., Feldman, T., Stahle, E., Escaned, J., Banning, A. P., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013042 · Cited by 190
Reversals of Established Medical Practices: Evidence to Abandon Ship
Prasad, V., Cifu, A., & Ioannidis, J. P. A. (2012) · JAMA · doi:10.1001/jama.2011.1960 · Cited by 187
Shaw, L. J., Weintraub, W. S., Maron, D. J., Hartigan, P. M., Hachamovitch, R., Min, J. K., Dada, M., Mancini, G. B. J., Hayes, S. W., O'Rourke, R. A., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.05.018 · Cited by 187
“The methods of the COURAGE trial were described previously.(1,21) In brief, participation in substudy 0 was elective, and sites had the discretion to complete a case report form or submit the imaging data to the COURAGE nuclear core laboratory, if the prior stress imaging study was performed within 2 months before ran…”
MethodInfluentialSelf-citationPatterns and Intensity of Medical Therapy in Patients Undergoing Percutaneous Coronary Intervention
Borden, W. B. (2011) · JAMA · doi:10.1001/jama.2011.601 · Cited by 188
Chacko, L., P. Howard, J., Rajkumar, C., Nowbar, A. N., Kane, C., Mahdi, D., Foley, M., Shun-Shin, M., Cole, G., Sen, S., et al. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006363 · Cited by 186
Subclinical atherosclerosis: what it is, what it means and what we can do about it
Toth, P. P. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01804.x · Cited by 187
EuroCMR (European Cardiovascular Magnetic Resonance) Registry
Bruder, O., Schneider, S., Nothnagel, D., Dill, T., Hombach, V., Schulz-Menger, J., Nagel, E., Lombardi, M., van Rossum, A. C., Wagner, A., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.003 · Cited by 187
Bangalore, S., Maron, D. J., Stone, G. W., & Hochman, J. S. (2020) · Circulation · doi:10.1161/circulationaha.120.048194 · Cited by 187
Self-citationTechnology Diffusion and Productivity Growth in Health Care
Skinner, J., & Staiger, D. (2015) · Review of Economics and Statistics · doi:10.1162/rest_a_00535 · Cited by 185
Wijeysundera, D. N., Austin, P. C., Hux, J. E., Beattie, W. S., & Laupacis, A. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.07.006 · Cited by 184
“Similarly, readers’ pre-existing opinions influence the interpretation of negative trials, as evidenced by responses to a recent trial of percutaneous coronary intervention [34,35].”
BackgroundMolecular Basis of Restenosis and Novel Issues of Drug-Eluting Stents
Inoue, T., & Node, K. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0059 · Cited by 186
On behalf of the Cardiovascular Committee of the EANM, T. E. A. T. E., Flotats, A., Knuuti, J., Gutberlet, M., Marcassa, C., Bengel, F. M., Kaufmann, P. A., Rees, M. R., & Hesse, B. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1586-y · Cited by 187
“revascularization, while those with more severe ischaemia are more likely to benefit from invasive procedures [21, 22].”
BackgroundTrends in Cause of Death After Percutaneous Coronary Intervention
Spoon, D. B., Psaltis, P. J., Singh, M., Holmes, D. R., Gersh, B. J., Rihal, C. S., Lennon, R. J., Moussa, I. D., Simari, R. D., & Gulati, R. (2014) · Circulation · doi:10.1161/circulationaha.113.006518 · Cited by 184
Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction
Amarenco, P., Lavallée, P. C., Labreuche, J., Ducrocq, G., Juliard, J.-M., Feldman, L., Cabrejo, L., Meseguer, E., Guidoux, C., Adraï, V., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.584086 · Cited by 186
Patel, K. K., Spertus, J. A., Chan, P. S., Sperry, B. W., Al Badarin, F., Kennedy, K. F., Thompson, R. C., Case, J. A., McGhie, A. I., & Bateman, T. M. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz389 · Cited by 181
Self-citationSianos, G., Barlis, P., Di Mario, C., Papafaklis, M., Büttner, J., Galassi, A., Schofer, J., Werner, G., Lefevre, T., Louvard, Y., et al. (2008) · EuroIntervention · doi:10.4244/eijv4i1a15 · Cited by 179
Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins
Dedic, A., Lubbers, M. M., Schaap, J., Lammers, J., Lamfers, E. J., Rensing, B. J., Braam, R. L., Nathoe, H. M., Post, J. C., Nielen, T., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.045 · Cited by 177
Moussa, I. D., Klein, L. W., Shah, B., Mehran, R., Mack, M. J., Brilakis, E. S., Reilly, J. P., Zoghbi, G., Holper, E., & Stone, G. W. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25135 · Cited by 176
High Coronary Shear Stress in Patients With Coronary Artery Disease Predicts Myocardial Infarction
Kumar, A., Thompson, E. W., Lefieux, A., Molony, D. S., Davis, E. L., Chand, N., Fournier, S., Lee, H. S., Suh, J., Sato, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.075 · Cited by 176
Modelling Methods for Pharmacoeconomics and Health Technology Assessment: An Overview and Guide
Stahl, J. E. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00004 · Cited by 171
Rothberg, M. B., Sivalingam, S. K., Ashraf, J., Visintainer, P., Joelson, J., Kleppel, R., Vallurupalli, N., & Schweiger, M. J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-5-201009070-00005 · Cited by 174
Lotfi, A., Jeremias, A., Fearon, W. F., Feldman, M. D., Mehran, R., Messenger, J. C., Grines, C. L., Dean, L. S., Kern, M. J., & Klein, L. W. (2014) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25222 · Cited by 174
Skinner, J. (2011) · Handbook of Health Economics · doi:10.1016/b978-0-444-53592-4.00002-5 · Cited by 171
“survival or heart-attack benefit to their patients, although it did reduce pain and improve functioning modestly for several years (Boden et al., 2007).”
BackgroundRevascularization for Unprotected Left Main Stem Coronary Artery Stenosis
Taggart, D. P., Kaul, S., Boden, W. E., Ferguson, T. B., Guyton, R. A., Mack, M. J., Sergeant, P. T., Shemin, R. J., Smith, P. K., & Yusuf, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.067 · Cited by 169
Self-citationHoenig, M. R., Doust, J., Aroney, C. N., & Scott, I. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004815.pub2 · Cited by 168
Toth, G. G., Toth, B., Johnson, N. P., De Vroey, F., Di Serafino, L., Pyxaras, S., Rusinaru, D., Di Gioia, G., Pellicano, M., Barbato, E., et al. (2014) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.114.001608 · Cited by 166
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23438 · Cited by 166
“The usefulness of PCI to improve survival is uncertain in patients with 2- or 3-vessel CAD (with or without involvement of the proximal LAD artery) or 1-vessel proximal LAD disease (17, 45, 48, 74).”
Self-citationGielen, S., Laughlin, M. H., O’Conner, C., & Duncker, D. J. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2014.10.001 · Cited by 165
“Prospective randomized studies have documented that in patients with small ischemic areas (<10% of the myocardium), a treatment strategy with optimal medical therapy (OMT) plus exercise is not inferior to an interventional strategy.(20,21) In a small pilot study, 101 patients with significant coronary artery stenosis…”
BackgroundMancini, G. B. J., Gosselin, G., Chow, B., Kostuk, W., Stone, J., Yvorchuk, K. J., Abramson, B. L., Cartier, R., Huckell, V., Tardif, J.-C., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.05.013 · Cited by 166
“Many patients treated in this fashion will achieve quality of life and symptom resolution equivalent to that afforded by early revascularization, with equivalent long-term outcomes.(66-69) there is risk of atrioventricular block or excessive bradycardia (Strong Recommendation, High-Quality Evidence).”
BackgroundSelf-citationRadico, F., Zimarino, M., Fulgenzi, F., Ricci, F., Di Nicola, M., Jespersen, L., Chang, S. M., Humphries, K. H., Marzilli, M., & De Caterina, R. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy185 · Cited by 165
“0% in the medical therapyonly group of the COURAGE trial.(76) In the REACH registry, patients with stable angina showed an incidence of hospitalization for cardiovascular causes of about 26% at 43 months median follow-up.”
Whitlow, P. L., Burke, M. N., Lombardi, W. L., Wyman, R. M., Moses, J. W., Brilakis, E. S., Heuser, R. R., Rihal, C. S., Lansky, A. J., & Thompson, C. A. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.01.014 · Cited by 165
Diretriz Brasileira de Reabilitação Cardiovascular – 2020
Carvalho, T. D., Milani, M., Ferraz, A. S., Silveira, A. D. D., Herdy, A. H., Hossri, C. A. C., Silva, C. G. S. E., Araújo, C. G. S. D., Rocco, E. A., Teixeira, J. A. C., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200407 · Cited by 163
Recent advances in percutaneous coronary intervention
Hoole, S. P., & Bambrough, P. (2020) · Heart · doi:10.1136/heartjnl-2019-315707 · Cited by 162
Schwartz, A. L., Chernew, M. E., Landon, B. E., & McWilliams, J. M. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4525 · Cited by 162
Ronald, J. A., Chen, J. W., Chen, Y., Hamilton, A. M., Rodriguez, E., Reynolds, F., Hegele, R. A., Rogers, K. A., Querol, M., Bogdanov, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.813998 · Cited by 162
Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
Farkouh, M. E., Boden, W. E., Bittner, V., Muratov, V., Hartigan, P., Ogdie, M., Bertolet, M., Mathewkutty, S., Teo, K., Maron, D. J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.044 · Cited by 162
Self-citationAustin, P. C., Manca, A., Zwarenstein, M., Juurlink, D. N., & Stanbrook, M. B. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.002 · Cited by 159
Hemingway, H., Philipson, P., Chen, R., Fitzpatrick, N. K., Damant, J., Shipley, M., Abrams, K. R., Moreno, S., McAllister, K. S. L., Palmer, S., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000286 · Cited by 161
“This reporting of risk prediction is of wide clinical interest because stable coronary disease has a high annual risk of fatal and nonfatal acute coronary syndromes of between 2% [36] and 5% [37,38] and affects an increasing number of people [39] as the population ages and survival from acute coronary syndromes improv…”
BackgroundChang, H.-J., Lin, F. Y., Gebow, D., An, H. Y., Andreini, D., Bathina, R., Baggiano, A., Beltrama, V., Cerci, R., Choi, E.-Y., et al. (2019) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2018.09.018 · Cited by 159
Self-citationSex differences in mechanisms, presentation and management of ischaemic heart disease
Crea, F., Battipaglia, I., & Andreotti, F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.802 · Cited by 159
Crea, F., Merz, C. N. B., Beltrame, J. F., Berry, C., Camici, P. G., Kaski, J. C., Ong, P., Pepine, C. J., Sechtem, U. P., & Shimokawa, H. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy857 · Cited by 160
Davidson, M. H., Corson, M. A., Alberts, M. J., Anderson, J. L., Gorelick, P. B., Jones, P. H., Lerman, A., McConnell, J. P., & Weintraub, H. S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.019 · Cited by 158
Shaw, L. J., Cerqueira, M. D., Brooks, M. M., Althouse, A. D., Sansing, V. V., Beller, G., Pop‐Busui, R., Taillefer, R., CHAITMAN, B. R., Gibbons, R. J., et al. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9548-3 · Cited by 156
Self-citationSurvival After Invasive or Conservative Management of Stable Coronary Disease
Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O’Brien, S. M., Mavromichalis, S., Chang, M., Contreras, A., Rosenberg, Y., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.062714 · Cited by 153
Self-citationOutcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States
Fanaroff, A. C., Zakroysky, P., Dai, D., WOJDYLA, D. M., Sherwood, M. W., Roe, M. T., Wang, T. Y., Peterson, E. D., Gurm, H. S., Cohen, M. G., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.032 · Cited by 155
“Additionally, data from both studies pre-dated the publication of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial and the 2012 Appropriate Use Criteria for Coronary Revascularization, which may have changed operator volumes (16,24).”
MethodInohara, T., Kohsaka, S., Spertus, J. A., Masoudi, F. A., Rumsfeld, J. S., Kennedy, K. F., Wang, T. Y., Yamaji, K., Amano, T., & Nakamura, M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.037 · Cited by 166
Self-citationClinical utility of polygenic risk scores for coronary artery disease
Klarin, D., & Natarajan, P. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00638-w · Cited by 152
Navarese, E. P., Lansky, A. J., Kereiakes, D. J., Kubica, J., Gurbel, P. A., Gorog, D. A., Valgimigli, M., Curzen, N., Kandzari, D. E., Bonaca, M. P., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab246 · Cited by 151
Gaba, P., Gersh, B. J., Muller, J. E., Narula, J., & Stone, G. W. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00769-8 · Cited by 174
From vulnerable plaque to atherothrombosis
Thim, T., Hagensen, M. K., Bentzon, J. F., & Falk, E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01947.x · Cited by 182
Late sodium current inhibition as a new cardioprotective approach
Hale, S. L., Shryock, J. C., Belardinelli, L., Sweeney, M. L., & Kloner, R. A. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.019 · Cited by 158
“The results of the COURAGE trial therefore suggest that optimal medical therapy is as good as PCI for major outcomes in patients with stable coronary artery disease [98].”
BackgroundResultGuiding Therapy by Coronary CT Angiography Improves Outcomes in Patients With Stable Chest Pain
Adamson, P. D., Williams, M. C., Dweck, M. R., Mills, N. L., Boon, N. A., Daghem, M., Bing, R., Moss, A. J., Mangion, K., Flather, M. D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.07.085 · Cited by 164
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E. A., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J. H., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.052 · Cited by 177
“For patients with obstructive CAD and stable chest pain, it is recommended to optimize GDMT (153,154,304).”
BackgroundInfluentialSelf-citationNovel HDL-directed pharmacotherapeutic strategies
deGoma, E. M., & Rader, D. J. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.200 · Cited by 149
“In the best-case scenario of intensive treatment and vigilant monitoring, the incidence of 'hard' cardiovascular events in secondary prevention cohorts is 20% after 4–5 years”
BackgroundDiamond, G. A., & Kaul, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.083 · Cited by 150
Myocardial stunning and hibernation revisited
Heusch, G. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00506-7 · Cited by 159
Oldridge, N. (2012) · Future Cardiology · doi:10.2217/fca.12.34 · Cited by 147
Percutaneous Coronary Intervention in 2018
Bhatt, D. L. (2018) · JAMA · doi:10.1001/jama.2018.5281 · Cited by 147
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23390 · Cited by 406
“Neither COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) (82) nor BARI 2D (116), which treated all patients with contemporary optimal medical therapy, demonstrated any survival advantage with PCI, although these trials were not specifically powered for this endpoint.”
InfluentialSelf-citationMyocardial Ischemia in Women: Lessons From the NHLBI WISE Study
Gulati, M., Shaw, L. J., & Merz, C. N. B. (2012) · Clinical Cardiology · doi:10.1002/clc.21966 · Cited by 164
Self-citationStress Perfusion CMR in Patients With Known and Suspected CAD
Vincenti, G. M., Masci, P. G., Monney, P. A., Rutz, T., Hugelshofer, S., Gaxherri, M., Müller, O., Iglesias, J. F., Eeckhout, É., Lorenzoni, V., et al. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.02.006 · Cited by 154
“Patients who underwent coronary revascularization #90 days after the index examination (early coronary revascularization) were not censored (18).”
Fractional flow reserve as a surrogate for inducible myocardial ischaemia
van de Hoef, T. P., Meuwissen, M., Escaned, J., Davies, J. E., Siebes, M., Spaan, J. A. E., & Piek, J. J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.86 · Cited by 144
Primary and Secondary Prevention of Cardiovascular Diseases: A Practical Evidence-Based Approach
O’Keefe, J. H., Carter, M. D., & Lavie, C. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.8.741 · Cited by 173
Stone, G. W., Ellis, S. G., Gori, T., Metzger, D. C., Stein, B., Erickson, M., Torzewski, J., Williams, J. E., Lawson, W. B., Broderick, T. M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32283-9 · Cited by 144
Coronary blood flow in heart failure: cause, consequence and bystander
Heusch, G. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00909-8 · Cited by 150
“that from revascularization in patients with stable coronary artery disease and angina is contentious, [18, 137] it is particularly the group of patients with coronary artery disease and ischemic heart failure who benefit from coronary revascularization.”
BackgroundTreatment of refractory angina in patients not suitable for revascularization
Henry, T. D., Satran, D., & Jolicoeur, M. E. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.200 · Cited by 154
Stent Thrombosis With Drug-Eluting Stents
Palmerini, T., Biondi‐Zoccai, G., Riva, D. D., Mariani, A., Généreux, P., Branzi, A., & Stone, G. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.725 · Cited by 139
“Similarly, important trials completed in the past decade that have examined the relative risks and benefits of PCI versus medical therapy in stable coronary artery disease (42) and PCI versus coronary artery bypass grafting in complex coronary artery disease (43) have exclusively used first-generation DES or BMS.”
BackgroundMathew, R. O., Bangalore, S., Lavelle, M. P., Pellikka, P. A., Sidhu, M. S., Boden, W. E., & Asif, A. (2016) · Kidney International · doi:10.1016/j.kint.2016.09.049 · Cited by 146
Self-citationWackers, F. J. T., Chyun, D. A., Young, L. H., Heller, G. V., Iskandrian, A. E., Davey, J. A., Barrett, E. J., Taillefer, R., Wittlin, S. D., Filipchuk, N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-1250 · Cited by 137
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain
Gulati, M., Levy, P. D., Mukherjee, D., Amsterdam, E. A., Bhatt, D. L., Birtcher, K. K., Blankstein, R., Boyd, J. H., Bullock-Palmer, R. P., Conejo, T., et al. (2021) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2021.11.009 · Cited by 162
Self-citationThe Frequency of Medical Reversal
Prasad, V. K., Gall, V., & Cifu, A. S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.295 · Cited by 139
Chronic Coronary Artery Disease
Pai, R. G., Varadarajan, P., & Pai, S. M. (2018) · Cardiology board review · doi:10.1002/9781118698983.ch10 · Cited by 136
Walther, C., Möbius-Winkler, S., Linke, A., Bruegel, M., Thiery, J., Schuler, G., & Halbrecht, R. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f29aa6 · Cited by 135
The Role of Coronary Artery Disease in Heart Failure
Lala, A., & Desai, A. S. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.10.002 · Cited by 168
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Hochman, J. S., Reynolds, H. R., Bangalore, S., O’Brien, S. M., Alexander, K. P., Senior, R., Boden, W. E., Stone, G. W., Goodman, S. G., Lópes, R. D., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0014 · Cited by 135
Self-citationThe Impact of Revascularization on Mortality in Patients with Nonacute Coronary Artery Disease
Jeremias, A., Kaul, S., Rosengart, T. K., Gruberg, L., & Brown, D. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.07.027 · Cited by 134
Doukky, R., Hayes, K., Frogge, N., Balakrishnan, G., Dontaraju, V. S., Rangel, M. O., Golzar, Y., Garcia-Sayan, E. D., & Hendel, R. C. (2013) · Circulation · doi:10.1161/circulationaha.113.002744 · Cited by 137
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.